Web Analytics

3 Latest Announced Rounds

  • $67,000,000
    Series A
    Biotechnology Research
    Apr 2nd, 2025
  • $10,000,000
    Seed

    2 Investors

    Software Development
    Apr 2nd, 2025
  • $5,200,000
    Series A

    3 Investors

    Technology, Information and Internet
    Apr 2nd, 2025
$1,666.17M Raised in 52 Funding Rounds in the past 7 Days - View All

Funding Round Profile

Crossbow Therapeutics, Inc

start up
United States - Cambridge, MA
  • 12/07/2023
  • Series A
  • $80,000,000

Crossbow Therapeutics, Inc., is a biotechnology company determined to improve the lives of people with cancer by unlocking the therapeutic potential of T-cell receptor (TCR)-mimetic antibodies. The company’s T-Bolt™ therapies are next-generation, easily assembled immunotherapies directed with high precision at previously unreachable cancer cell targets. Crossbow’s efficient and selective approach is designed to target the entire universe of cancer proteins, dramatically expanding the potential of antibody therapy to address many types of cancer.


Related People

Geraldine PaulusCo Founder

Geraldine Paulus United States - Cambridge, Massachusetts

N/A



Submit A Correction
Submit A Correction

Submit The Correction On the Page